View web version

This week Chicago said it will require pharma reps to track their calls; Roche received FDA approval for its immunotherapy Tecentriq; Pfizer announced plans to start selling its Remicade biosimilar in November; and Doctors Without Borders refused free Pfizer vaccines

Attending Digital Pharma East next week? Let us know. Got a news pitch for next week's morning roundup? Email

This Week's News
Five things for pharma marketers to know: Friday, October 21, 2016
Guidemark Health merges with three companies to form new agency
StartUp Health reports more global deals, uptick in pharma investment in digital health
Why Excedrin embraced the headache of a contentious election season
The 50-plus consumer is driven by curiosity and wonder, finds Ketchum study
Cleveland Clinic's Cosgrove: Obamacare now 'part of the fabric' of the U.S.
The Latest in Opinion
FCB Health's Rich Levy on HIV/AIDS Campaigns that Fight Stigma
By Rich Levy, FCB Health
To Move the Needle on Gender Parity, Execs Must Admit Bias
By Michelle Keefe, Publicis Health
Adding Support at the Point of Care May Also Improve Access to Docs
By Lynn O'Connor Vos, ghg
Trump or Clinton? Either May Lead to Better Mental Healthcare
By Keri McDonough, Biosector 2

For details on how to advertise in MM&M Weekly Digest, please email Doreen Gates

To unsubscribe from the MM&M Weekly Digest click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
275 7th Avenue, 10th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150

© 2016 Haymarket Media Inc.